vaccin
protect
respiratori
infect
optim
induc
mucos
immun
respons
respiratori
tract
addit
system
immun
respons
howev
current
parenter
immun
modal
gener
fail
induc
mucos
immun
mucos
vaccin
deliveri
often
result
poor
system
immun
order
find
immun
strategi
satisfi
need
induct
mucos
system
immun
compar
local
system
immun
respons
elicit
two
mucos
immun
given
either
intranas
intrapulmonari
ipl
rout
respons
elicit
mucos
prime
follow
system
boost
immun
studi
conduct
balbc
mice
vaccin
formul
influenza
subunit
vaccin
supplement
saponinderiv
adjuv
optim
mucos
antibodi
titer
obtain
two
intrapulmonari
vaccin
optim
system
antibodi
respons
achiev
intranas
prime
follow
intramuscular
boost
latter
strategi
also
result
best
cell
respons
yet
ineffect
induc
nose
lung
iga
success
induct
secretori
iga
igg
cell
respons
achiev
primeboost
strategi
involv
intrapulmonari
immun
optim
immun
given
via
intrapulmonari
rout
result
underlin
immun
via
lung
particularli
effect
prime
well
boost
local
system
immun
respons
citat
liu
h
patil
hp
de
vriesidema
j
wilschut
j
huckried
evalu
mucos
system
immun
respons
elicit
influenza
vaccin
deliv
differ
immun
strategi
plo
one
aim
mucos
immun
respiratori
viru
infect
induct
local
immun
port
pathogen
entri
particular
mucos
antibodi
readili
neutral
invad
virus
lumin
site
epitheli
layer
prevent
entri
host
cell
immun
exclus
effect
mainli
mediat
secretori
iga
siga
effect
induc
mucos
parenter
immun
moreov
intracellular
virus
neutral
transcytosi
dimer
siga
epitheli
layer
furthermor
rapidli
chang
virus
like
influenza
viru
siga
shown
crossreact
igg
neutral
antigendrift
homosubtyp
even
antigenshift
heterosubtyp
viru
strain
despit
advantag
mucos
immun
induct
siga
respons
mucos
rout
suboptim
induct
system
antibodi
respons
case
influenza
system
antibodi
import
sinc
contribut
protect
viru
replic
lung
correl
protect
far
recogn
regulatori
author
furthermor
due
default
natur
mucos
immun
mucos
immun
show
limit
induct
antibodi
subtyp
eg
balbc
mice
prefer
viral
clearanc
potenti
way
combin
advantag
mucos
system
immun
involv
primeboost
strategi
mucos
prime
system
boost
viceversa
sever
studi
investig
strategi
major
make
use
dna
vaccin
andor
recombin
viru
vaccin
prime
boost
far
littl
known
primeboost
strategi
optim
mucos
system
immun
respons
proteinbas
influenza
vaccin
studi
hors
use
iscomadjuv
influenza
vaccin
show
intranas
boost
intramuscular
im
prime
much
effect
serum
igg
level
result
low
transient
siga
igg
respons
nose
wash
howev
comparison
perform
altern
immun
strategi
earlier
show
semisynthet
saponinderiv
effect
adjuv
influenza
subunit
vaccin
administ
via
intramuscular
also
intranas
particularli
intrapulmonari
rout
use
influenza
vaccin
identifi
immun
strategi
effect
elicit
influenzaspecif
immun
respons
mucos
system
site
end
compar
immun
respons
elicit
two
mucos
strategi
adjuv
influenza
vaccin
respons
obtain
strategi
involv
mucos
prime
follow
system
booster
immun
two
differ
mucos
administr
rout
evalu
intranas
intrapulmonari
ipl
observ
system
boost
effect
mucos
boost
induct
mucos
siga
system
boost
enhanc
system
igg
titer
higher
level
mucos
boost
inprim
iplprim
mice
yet
system
boost
gener
stimul
stronger
cellular
immun
mucos
boost
immun
strategi
test
current
studi
provid
complet
protect
influenza
viru
infect
purchas
hawaii
biotech
inc
aiea
hi
usa
store
mgml
stock
solut
prepar
hb
buffer
mm
hepe
mm
nacl
mm
edta
ph
describ
previous
stock
apuerto
influenza
viru
propag
madindarbi
canin
kidney
mdck
cell
kindli
provid
solvay
biolog
weesp
netherland
propag
embryon
egg
viru
titer
determin
measur
tissu
cultur
infecti
dose
tcid
subunit
vaccin
prepar
procedur
previous
describ
briefli
viru
inactiv
citrat
buffer
freshli
prepar
inactiv
viru
sampl
dialyz
hb
buffer
mm
hepe
mm
nacl
mm
edta
ph
solubil
tween
mgml
hexadecyltrimethylammonium
bromid
ctab
mgml
viral
nucleocapsid
remov
prepar
ultracentrifug
subsequ
deterg
remov
biobead
mgml
biorad
hercul
canada
prewash
methanol
protein
content
subunit
materi
determin
modifi
lowri
assay
hemagglutinin
ha
content
assum
equal
total
protein
subunit
materi
base
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
result
indic
presenc
minor
amount
viral
protein
vaccin
mix
indic
amount
subunit
immun
protocol
anim
experi
describ
approv
ethic
committe
anim
research
univers
groningen
immun
experi
femal
balbc
mice
harlan
horst
netherland
age
week
group
n
per
group
immun
im
ipl
subunit
vaccin
without
twodos
immun
regimen
day
interv
tabl
im
immun
vaccin
divid
hind
leg
immun
vaccin
slowli
deliv
pipet
divid
nare
thu
confin
antigen
nose
ipl
immun
mice
brought
upright
posit
isofluran
anesthesia
trachea
intub
modifi
autoguard
cathet
becton
dickinson
bv
breda
netherland
vaccin
deliv
help
microspray
aerosol
attach
high
pressur
syring
penncenturi
inc
wyndmoor
pa
usa
preboost
blood
sampl
collect
day
orbit
punctur
prior
second
immun
immun
experi
mice
sacrif
day
nose
wash
lung
wash
blood
spleen
sampl
collect
ex
vivo
immunoassay
mucos
wash
sampl
collect
ml
phosphatebuff
salin
pb
contain
proteas
inhibitor
complet
proteas
inhibitor
cocktail
roch
usa
challeng
experi
mice
receiv
immun
regimen
describ
preboost
prechalleng
serum
sampl
collect
day
day
orbit
punctur
prior
immun
viru
infect
respect
day
mice
infect
intranas
tcid
influenza
viru
hb
buffer
viru
infect
carri
isofluran
anesthesia
ensur
deposit
viru
lung
mice
monitor
twice
day
fix
time
point
clinic
sign
ill
includ
weight
loss
chang
behavior
appear
mice
bled
sacrif
day
nasal
wash
serum
spleen
sampl
collect
immunoassay
lung
lobe
collect
ml
pb
homogen
process
sampl
store
later
determin
lung
viru
titer
antibodi
respons
determin
elisa
previous
describ
nasal
siga
igg
respons
od
individu
sampl
given
lung
siga
igg
respons
averag
od
standard
error
mean
sem
group
dilut
calcul
serum
igg
respons
titer
individu
sampl
calcul
log
reciproc
sampl
dilut
correspond
od
calcul
purpos
sera
titer
detect
limit
assign
arbitrari
titer
correspond
half
detect
limit
calibr
plate
assay
coat
goat
antimous
igg
southernbiotech
increas
concentr
purifi
mous
southernbiotech
ad
plate
respons
detect
individu
sampl
given
concentr
serum
sampl
process
hai
titer
determin
describ
previous
log
hai
titer
individu
mice
present
elispot
respons
determin
elispot
assay
previous
describ
number
influenzaspecif
cell
per
splenocyt
mous
given
lung
collect
immun
challeng
mice
homogen
pb
store
use
viru
titer
determin
inocul
serial
dilut
clarifi
homogen
mdck
cell
describ
earlier
titer
individu
mice
given
result
present
log
viru
titer
per
gram
lung
tissu
unpair
student
ttest
use
determin
differ
influenzaspecif
respons
observ
group
mice
signific
p
valu
p
consid
signific
spearman
nonparametr
correl
analysi
perform
assess
relationship
observ
serum
mucos
influenzaspecif
igg
respons
sinc
induct
mucos
siga
respons
central
aim
mucos
immun
first
evalu
effect
immun
strategi
induc
siga
respons
mice
receiv
influenza
vaccin
via
ipl
rout
day
receiv
second
immun
day
via
mucos
rout
im
control
group
immun
twice
im
nonadjuv
vaccin
serv
refer
six
mice
group
sacrif
one
week
booster
immun
collect
lung
wash
sampl
six
mice
group
challeng
viru
two
week
booster
sacrif
three
day
later
collect
nose
wash
sampl
siga
elisa
perform
lung
wash
sampl
show
mice
prime
adjuv
vaccin
via
rout
develop
detect
lung
siga
titer
mucos
system
booster
figur
contrast
lung
siga
readili
detect
mice
prime
via
ipl
rout
boost
either
via
rout
via
im
rout
yet
iplipl
approach
result
significantli
higher
lung
siga
titer
iplim
approach
pm
expect
imim
immun
refer
group
develop
detect
lung
siga
titer
siga
elisa
nose
wash
sampl
reveal
inprim
mice
develop
detect
nasal
siga
respons
even
booster
via
mucos
system
rout
challeng
live
viru
figur
contrast
iplprim
mice
develop
robust
nasal
siga
respons
booster
given
also
via
ipl
rout
comparison
pm
margin
siga
amount
found
nose
wash
imimimmun
anim
mucos
igg
suggest
play
role
lung
protect
influenza
viru
infect
evalu
effect
differ
immun
strategi
lung
nose
igg
respons
mice
prime
vaccin
boost
im
develop
significantli
higher
level
lung
igg
figur
nose
igg
figur
mice
prime
boost
via
rout
comparison
nm
group
figur
respect
interestingli
mice
prime
ipl
vaccin
boost
im
develop
significantli
lower
lung
igg
titer
immun
ipl
prime
boost
p
comparison
pm
group
figur
respect
igg
titer
differ
immun
group
imim
control
group
low
level
igg
detect
lung
wash
nose
wash
taken
togeth
result
indic
ipl
immun
optim
prime
boost
mucos
antibodi
respons
rout
ineffect
prime
boost
mucos
respons
subunit
vaccin
next
evalu
effect
immun
strategi
system
antibodi
respons
elicit
influenza
vaccin
ipl
prime
result
detect
igg
respons
day
figur
yet
titer
significantli
lower
inprim
mice
sera
immun
mice
collect
two
week
booster
prior
viru
challeng
igg
elisa
perform
serum
sampl
show
mice
tabl
level
signific
depict
follow
p
p
p
doi
similar
imimimmun
control
group
figur
igg
respons
mice
immun
inim
approach
nm
significantli
enhanc
averag
titer
p
comparison
nm
group
hand
iplprim
mice
booster
rout
signific
effect
serum
igg
respons
iplipl
iplimimmun
mice
respect
sera
immun
challeng
mice
collect
three
day
challeng
upon
sacrific
evalu
hemagglutinationinhibit
hai
titer
mice
immun
plain
influenza
vaccin
imim
immun
develop
averag
loghai
titer
figur
none
mice
receiv
influenza
vaccin
inin
immun
develop
detect
hai
titer
howev
mice
receiv
adjuv
vaccin
inim
approach
develop
detect
serum
hai
titer
averag
titer
similar
imim
control
group
mice
receiv
adjuv
vaccin
iplipl
iplim
develop
compar
serum
hai
titer
averag
titer
somewhat
lower
obtain
control
group
imin
regimen
yet
differ
reach
statist
signific
taken
togeth
immun
strategi
involv
mucos
prime
follow
system
boost
improv
system
antibodi
respons
elicit
ipl
vaccin
administr
next
examin
phenotyp
antibodi
respons
perform
elisa
assay
postchalleng
serum
sampl
mention
mice
receiv
plain
influenza
vaccin
imim
immun
develop
serum
averag
figur
receiv
influenza
vaccin
inin
vaccin
howev
bare
develop
detect
serum
respons
inim
deliveri
adjuv
vaccin
result
significantli
enhanc
respons
averag
robust
serum
respons
observ
mice
receiv
adjuv
vaccin
iplipl
iplim
immun
averag
serum
respect
respons
low
mice
immun
twice
im
ipl
except
one
mous
ipl
group
figur
interestingli
system
boost
result
significantli
enhanc
serum
respons
inprim
mice
comparison
nm
contrast
system
boost
neg
effect
titer
iplprim
mice
irrespect
immun
strategi
overal
antibodi
respons
elicit
subunit
influenza
vaccin
domin
antibodi
subtyp
evalu
effect
immun
strategi
cellular
immun
respons
elicit
influenza
vaccin
spleen
immun
mice
collect
one
week
booster
upon
termin
respons
bare
detect
mice
receiv
plain
evalu
effect
immun
strategi
protect
viru
challeng
immun
mice
infect
live
viru
day
booster
immun
lung
viru
titer
determin
three
day
later
peak
viral
replic
mockimmun
control
mice
develop
averag
lung
viru
titer
logg
lung
tissu
figur
lung
viru
titer
detect
limit
mice
imimmun
control
group
one
mous
group
develop
titer
logg
lung
tissu
lung
viru
titer
detect
mice
receiv
influenza
vaccin
either
twice
via
one
mucos
rout
mucos
prime
follow
system
boost
thu
adjuv
vaccin
provid
complet
protect
lung
viru
growth
irrespect
immun
strategi
follow
present
studi
evalu
effect
immun
strategi
immunogen
protect
capac
influenza
subunit
vaccin
interestingli
observ
optim
boost
rout
inand
iplprim
mice
differ
inprim
mice
develop
mucos
poor
system
antibodi
respons
boost
via
rout
boost
inprim
mice
via
im
rout
howev
result
detect
mucos
igg
though
siga
respons
strong
system
antibodi
respons
enhanc
cell
respons
induct
antibodi
subtyp
associ
improv
viru
clearanc
iplprim
mice
iplipl
immun
effect
induc
mucos
siga
igg
well
system
antibodi
iplim
approach
hand
result
rel
modest
mucos
antibodi
respons
although
equal
effect
iplipl
strategi
induct
system
antibodi
respons
despit
differ
immun
profil
challeng
experi
show
influenza
vaccin
deliv
regim
provid
complet
protect
lung
homolog
viru
infect
result
reveal
mucos
immun
respons
primeboost
immun
affect
prime
well
boost
rout
prime
use
low
vaccin
volum
retain
antigen
nasal
caviti
allow
us
clearli
distinguish
ipl
immun
observ
ipl
immun
effect
induc
mucos
siga
well
igg
respons
robust
mucos
antibodi
titer
observ
iplipl
group
could
result
success
induct
local
memori
respons
poor
mucos
respons
inin
group
indic
deliveri
influenza
vaccin
use
current
studi
bare
prime
mucos
respons
yet
im
boost
inprim
mice
though
induc
mucos
siga
respons
elicit
mucos
igg
respons
report
mucos
igg
deriv
serum
present
high
concentr
reach
nose
especi
lung
transud
inde
except
iplipl
group
mucos
serum
igg
respons
elicit
group
share
trend
inin
imim
inim
ipim
posit
correl
mucos
serum
igg
respons
group
confirm
spearman
analysi
coeffici
nose
igg
vs
serum
igg
lung
igg
vs
serum
igg
p
respect
result
gener
line
earlier
studi
minn
cowork
test
extent
deliveri
site
respiratori
tract
impact
immun
respons
elicit
influenza
vaccin
author
use
mice
prime
whole
inactiv
viru
vaccin
administ
volum
prime
mice
boost
administr
split
antigen
differ
part
respiratori
tract
hind
muscl
boost
result
poor
mucos
antibodi
respons
except
nose
siga
administr
deep
lung
elicit
strong
nose
lung
siga
igg
respons
observ
studi
im
boost
effect
stimul
mucos
siga
boost
mucos
igg
respons
similar
extent
boost
deep
lung
thu
agreement
previou
studi
conclud
ipl
rout
much
effect
rout
prime
mucos
antibodi
respons
moreov
optim
rout
boost
respons
next
mucos
antibodi
system
igg
antibodi
play
import
role
protect
sever
influenza
ill
sinc
transud
lung
prevent
excess
viral
replic
tissu
damag
upon
infect
basi
protect
provid
convent
parenter
administ
influenza
vaccin
studi
prime
via
either
ipl
rout
result
detect
serum
igg
respons
day
later
although
respons
significantli
lower
inprim
mice
figur
boost
stimul
serum
igg
respons
hai
titer
could
detect
im
boost
essenti
achiev
system
antibodi
respons
compar
even
better
control
group
immun
im
nonadjuv
vaccin
therefor
even
though
prime
elicit
modest
serum
antibodi
respons
memori
b
cell
form
prime
could
readili
activ
upon
im
boost
yet
optim
boost
requir
antigen
administr
via
im
rout
result
confirm
earlier
result
studi
influenza
hsv
sar
found
prime
whether
given
protein
dna
recombin
viru
vaccin
follow
im
boost
induct
optim
serum
antibodi
respons
iplprim
mice
im
ipl
boost
equal
effect
elicit
serum
igg
hai
titer
also
earlier
studi
studi
minn
et
al
ipl
boost
found
result
particularli
strong
system
antibodi
respons
thu
strong
system
antibodi
respons
achiev
either
two
ipl
immun
ipl
prime
follow
im
boost
addit
magnitud
phenotyp
immun
respons
also
determin
effect
protect
invad
pathogen
type
immun
respons
character
product
mice
shown
correl
posit
improv
protect
influenza
viru
yet
immun
bare
induc
imim
immun
plain
influenza
vaccin
inin
immun
influenza
vaccin
im
boost
inprim
mice
significantli
enhanc
arm
immun
respons
superior
qualiti
immun
respons
elicit
inim
immun
inin
immun
even
imim
immun
unadjuv
vaccin
line
earlier
studi
ipl
immun
influenza
vaccin
elicit
margin
respons
use
iplipl
approach
interestingli
im
boost
somewhat
decreas
respons
significantli
enhanc
respons
iplprim
mice
contrast
studi
minn
et
al
show
im
ipl
boost
effect
elicit
respons
differ
result
two
studi
possibl
due
differ
vaccin
formul
use
minn
et
al
use
high
dose
ha
whole
inactiv
viru
wiv
low
dose
ha
split
viru
prime
boost
respect
wiv
possess
natur
adjuv
activ
ssrna
ligand
effect
induc
respons
subunit
vaccin
use
current
studi
hand
rather
ineffect
elicit
respons
result
immun
phenotyp
although
im
boost
enhanc
immun
ipl
vaccin
differ
extent
overal
immun
respons
elicit
influenza
vaccin
administ
follow
differ
immun
strategi
domin
phenotyp
taken
togeth
immun
strategi
involv
mucos
prime
follow
system
booster
iplipl
properli
adjuv
influenza
vaccin
least
effect
convent
parenter
immun
induc
system
antibodi
respons
import
sinc
regulatori
author
request
influenza
vaccin
fulfil
qualiti
criteria
base
serum
hai
titer
meanwhil
pulmonari
immun
probabl
also
rais
local
memori
b
cell
cell
respons
respiratori
tract
phenomenon
observ
upon
influenza
infect
upon
intramuscular
immun
thu
mucos
prime
essenti
local
memori
immunocyt
respiratori
tract
would
allow
respond
rapidli
influenza
viru
challeng
moreov
memori
b
cell
prime
mucos
system
rout
preferenti
express
siga
major
antibodi
subtyp
mediat
earli
immun
exclus
also
exhibit
crossprotect
capac
henc
inim
iplim
iplipl
immun
regimen
explor
come
optim
immun
regimen
protect
respiratori
viral
infect
figur
system
igg
prime
differ
immun
rout
serum
sampl
mice
describ
legend
figur
collect
day
prior
second
immun
total
igg
respons
nm
pm
group
prime
given
tif
